HeyJaredKatie Lennon
- Indexed articles, last 90 days
- 25
- Latest publication
- Sep 11, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer (opens the original)
Read excerpt
Circulating tumor DNA (ctDNA) detected via a tissue-free epigenomic assay approximately 2 years after adjuvant chemotherapy strongly predicts distant recurrence in patients with early-stage breast cancer. Among 313 patients, ctDNA was detected in 18 samples, with 94% of these patients subsequently developing distant recurrence at a median of 7.9 months after detection. “Tissue-free detection of ctDNA 2 years after adjuvant chemotherapy was highly prognostic in an early-stage breast cancer cohort
BRCA Mutation Carriers Likely to Have Risk-Reducing Surgery (opens the original)
Read excerpt
Women with pathogenic variants (PVs) in BRCA1/2 genes were more than seven times as likely to undergo risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) as were those carrying genetic variants for which there is “insufficient evidence” for discussion, consideration, or recommendation related to use of either procedure for such patients. Pancreatic screening via endoscopic ultrasound (EUS) or magnetic resonance cholangiopancreatography (MRCP) was used by fewer than 11%
Young Adult Cancer Survival Rates Accelerate (opens the original)
Read excerpt
Adolescents and young adults (AYAs) with cancer in the United States experienced slower improvement in survival than younger and older patients before 1998 but have since shown greater improvement rates. From 2000 to 2017, AYAs achieved an average annual percent change (AAPC) surpassing both younger and older patients. “While compared with younger and older patients with cancer, American AYAs had the slowest improvement in 5-year relative survival before 1998, they since have had a greater impro
Diclofenac Did Not Reduce Chemo-Induced Hand-Foot Syndrome (opens the original)
Read excerpt
Prophylactic topical diclofenac does not reduce clinically significant hand-foot syndrome (HFS) in patients receiving capecitabine-based therapy, a new real-world observational study found. Grade ≥ 2 HFS occurred in approximately 17% vs 14% of patients using diclofenac gel vs those under active monitoring, with no difference in time to onset. “In this prospective real-world study, prophylactic topical diclofenac did not reduce clinically significant capecitabine-induced HFS or delay its onset co
Awareness of How to Spot Rare Breast Cancer Is Low (opens the original)
Read excerpt
General awareness of inflammatory breast cancer (IBC) does not translate into recognition of hallmark symptoms, according to survey responses from under 200 US adults. While more than 75% had heard of IBC, critical warning signs like skin thickening, nipple inversion, and peau d’orange were frequently missed by nearly half of participants. “These findings underscore the importance of public education that shifts awareness beyond breast lump detection to include the rapid onset of unilateral brea
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.